Association of peroxisome proliferator-activated receptor delta +294T/C with body mass index and interaction with peroxisome proliferator-activated receptor alpha L162V

International Journal of Obesity

Volumn 30, Issue 12, 2006, Pages 1709-1713

  Aberle, J ^a   Hopfer, I ^a   Beil, F U ^a   Seedorf, U ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Body mass index; Gene to gene interaction; Polygenetic metabolism; PPAR

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CAUCASIAN; DYSLIPIDEMIA; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANTHROPOMETRY; BODY CONSTITUTION; BODY MASS INDEX; BODY WEIGHT; DYSLIPIDEMIAS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LIPIDS; MALE; MIDDLE AGED; MULTIFACTORIAL INHERITANCE; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR ALPHA; PPAR DELTA; PPAR GAMMA;

EID: 33845256051     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803345     Document Type: Article

References (21)

1. James PT, Rigby N, Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prec Rehabil 2004; 11: 3-8.
2. Froguel P, Boutin P. Genetics of pathways regulating body weight in the development of obesity in humans. Exp Biol Med 2001; 226: 991-996.
3. Reddy JK, Hashimoto T. Peroxisomal β-oxidation and peroxisome proliferator activated receptor α: an adaptive metabolic system. Annu Rev Nutr 2001; 21: 193-230.
4. Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding the big picture. Cell 1996; 87: 377-389.
5. Skogsberg J, Kannisto R, Roshani L, Gagne E, Hamsten A, Larsson C et al. Characterization of the human peroxisome proliferator activated receptor delta gene and its expression. Int J Mol Med 2000; 6: 73-81.
6. Tai ES, Demissie S, Cupples LA, Corella D, Wilson PW, Schaefer EJ et al. Association between the PPARAL162V polymorphism and plasma lipid levels: the Framingham offspring study. Arterioscler Thromb Vasc Biol 2002; 22: 805-810.
7. Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodriguez de Fonseca F et al. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α. Nature 2003; 425: 90-93.
8. Skogsberg J, Kannisto K, Cassel TN, Hamsten A, Eriksson P, Ehrenborg E. Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men. Arterioscler Thromb Vasc Biol 2003; 23: 637-643.
9. Skogsberg J, McMahon AD, Karpe F, Hamsten A, Packard CJ, Ehrenborg E. Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men. J Int Med 2003; 254: 597-604.
10. Olivier WR, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL et al. A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport. Proc Nat Acad Sci USA 2001; 98: 5306-5311.
11. Leibowitz MD, Fievet C, Hennuyer N, Peinado-Onsurbe J, Duez H, Bergera J et al. Activation of PPAR delta alters lipid metabolism in db/db mice. FEBS Lett 2000; 473 (3): 333-336.
12. Luquet S, Lopez-Soriano J, Holst D, Fredenrich A, Melki J, Rassoulzandegan M et al. Peroxisome proliferator-activated receptor δ controls muscle development and oxidative capability. FASEB 2003; 17: 2299-2301.
13. Vänttinen M, Nuutila P, Kuulasmaa T, Pihlahamäki J, Hällsten K, Virtanan KA et al. Single Nucleotide Polymorphisms in the Peroxisome Proliferator-Activated Receptor δ Gene are associated with skeletal muscle glucose uptake. Diabetes 2005; 12: 3587-3591.
14. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J et al. A Pro12Ala substitution in PPARg2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-287.
15. Cole SA, Mitchell BC, Hsueh WC, Pineda P, Beamer BA, Shuldiner AR et al. The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma 2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans. Int J Obes Relat Metab Disord 2000; 24: 522-524.
16. Rust S, Funke H, Assmann G. Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection. Nucl Acid Res 1991; 21: 3623-3629.
17. Vohl MC, Lepage P, Gaudet D, Despres LP, Morgan K, Hudson TJ. Molecular scanning of the human PPARa gene. Association of the l162v mutation with hyperapobetolipoproteinemia. J Lipid Res 2000; 42: 945-952.
18. Yen CJ, Beamer BA, Negri C, Silver K, Bown KA, Yarnall DP et al. Molecular scanning of the human peroxisome proliferator activated receptor γ (HPPARγ) gene in diabetic Caucasions: identification of a Pro12Ala PPAR-g2 missense mutation. Biochem Biophys Res Commun 1997; 241: 270-274.
19. Wang YX, Chih-Hao L, Tiep S, Yu RT, Ham J, Kang H et al. Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obestiy. Cell 2003; 113: 159-170.
20. Stumvoll M, Häring H. The Peroxisome Proliferator-Activated Receptor-γ2 Pro12Ala Polymorphism. Diabetes 2003; 51: 2341-2347.
21. Robitaille J, Brouillette C, Houde A, Tchernof A, Vohl MC. Association between the PPAR α-L162V polymorphism and components of the metabolic syndrome. J Hum Genet 2004; 49: 482-489.